Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

37.5%

3 terminated/withdrawn out of 8 trials

Success Rate

57.1%

-29.4% vs industry average

Late-Stage Pipeline

50%

4 trials in Phase 3/4

Results Transparency

150%

6 of 4 completed trials have results

Key Signals

1 recruiting6 with results

Enrollment Performance

Analytics

Phase 2
3(42.9%)
Phase 3
3(42.9%)
Phase 4
1(14.3%)
7Total
Phase 2(3)
Phase 3(3)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

All 8 trials loaded